India Emerges as a Hub for Global R&D Investments

India has taken an early lead in attracting Research and Development (R&D) investments from global giants, surpassing established hubs such as Japan, Israel, and Western Europe. According to a survey by Tokyo's National Science Foundation, India is home to over 150 multinational companies, including IBM, Texas Instruments, Google, and General Electric, which have set up R&D centers in the country. These centers employ thousands of researchers and have filed numerous patents, with some centers emerging as crucial hubs for cutting-edge research.

Key Takeaways:

  • Over 150 global giants, including IBM, Texas Instruments, Google, and General Electric, have set up R&D centers in India.
  • India's R&D centers employ thousands of researchers and have filed numerous patents.
  • General Electric's R&D lab in Bangalore is its second-largest in the world, employing 1,600 researchers.
  • Oracle's R&D center in India is its largest outside the United States.
  • India's R&D spending reached $19 billion in 2000-01, according to the Organization for Economic Cooperation and Development.
  • The R&D market in India's IT sector is expected to grow from $1 billion to $10 billion by 2010.
  • Indian companies, such as Tata Motors, are increasing their R&D spending, with Tata Motors investing $66 million per year.
  • India's large talent pool and cost advantage make it an attractive destination for global R&D investments.
  • However, threats from countries such as China, Russia, and Malaysia are looming, as they attempt to grab a share of the MNCs' global R&D investments.

Statistics:

  • Over 150 multinational companies have set up R&D centers in India.
  • General Electric's R&D lab in Bangalore employs 1,600 researchers.
  • Oracle's R&D center in India is its largest outside the United States.
  • India's R&D spending reached $19 billion in 2000-01.
  • The R&D market in India's IT sector is expected to grow from $1 billion to $10 billion by 2010.
  • Indian companies, such as Tata Motors, are increasing their R&D spending, with Tata Motors investing $66 million per year.
  • India's cost advantage: it costs about $80 million to develop a new drug in the US, while the same costs $11 million in India.

Sources:

  • Tokyo's National Science Foundation survey
  • Organization for Economic Cooperation and Development report
  • Frost & Sullivan report
  • Confederation of Indian Industry report
  • India's National Science Foundation report
  • Press release by DaimlerChrysler
  • Press release by Oracle